• Info
  • Insider Ownership

Insider Trading & Ownership of Merck KGaA

Location
Darmstadt, Germany
Summary
The estimated value of insider holdings of Merck KGaA is at least $565,085 dollars as of 26 Oct 2021. Merck KGaA is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $565.1K.
Signature
/s/ Christian Uhrich, Authorized signatory of Merck KGaA, Darmstadt, Germany
All Insider Reports
All Insider Reports

Notify me when Merck KGaA files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Merck KGaA

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
XLO Xilio Therapeutics, Inc. 10%+ Owner $565,085 26 Oct 2021

Insider Transactions Reported by Merck KGaA:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.